Skip to main content

Susan Halabi CV

James B. Duke Distinguished Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Duke Box 2717, Durham, NC 27710
2424 Erwin Road 11th Floor, 11088 Hock Plaza, Durham, NC 27705
CV

Keywords


Adenocarcinoma Adenocarcinoma, Clear Cell African Americans Age Factors Aged, 80 and over Alkaline Phosphatase Alleles Arab countries Area Under Curve Biological Markers Biomarkers, Pharmacological Breast Neoplasms Cancer Vaccines Carcinoma Carcinoma, Renal Cell Case-Control Studies Chemoprevention Chemotherapy Chi-Square Distribution Clinical Trials, Phase II as Topic Clinical trials Cohort Studies Computer Simulation Confidence Intervals Construction Materials Contraceptives, Oral DNA Damage DNA Primers DNA Repair DNA, Neoplasm Data Interpretation, Statistical Decision Making Decision Support Techniques Diagnostic Imaging Disease Progression Disease-Free Survival Drug Design Dust Efficiency, Organizational Endpoint Determination Equipment Design Factor Analysis, Statistical Family relationships Gels Gene Expression Genes, Immunoglobulin Genetic Predisposition to Disease Genetics, Medical Genotype Germany Graft vs Host Disease HIV Infections Hispanic Americans Kaplan-Meier Estimate Ketoconazole Lasso Logistic Models Lymphokines Mining Models, Biological Models, Statistical Models, Theoretical Molecular Sequence Data Multiprotein Complexes Multivariate Analysis Mutation Neoplasms, Hormone-Dependent Nomograms Odds Ratio Outcome Assessment (Health Care) Ovarian Neoplasms Personalized medicine Population Population Surveillance Precision Medicine Predictive Value of Tests Pregnancy Probability Prognosis Proportional Hazards Models Prospective Studies ROC Curve Randomized Controlled Trials as Topic Receptors, Progesterone Registries Reproducibility of Results Research Design Residence Characteristics Retrospective Studies Ribosomal Protein S6 Kinases Risk Risk Assessment Risk Factors Sample Size Selective Estrogen Receptor Modulators Sensitivity and Specificity Statistics as Topic Survival Survival Analysis Survival Rate Tamoxifen Translocation, Genetic Treatment Failure Treatment Outcome Tumor Markers, Biological United States Urologic Neoplasms Validation Studies as Topic Vascular Endothelial Growth Factors